Literature DB >> 26022109

BRCA1 regulates transforming growth factor-β (TGF-β1) signaling through Gadd45a by enhancing the protein stability of Smad4.

Dan Li1, Nan Kang1, Junfang Ji1, Qimin Zhan2.   

Abstract

BRCA1 is a well established tumor suppressor gene, which is involved in many cellular processes, including DNA damage repair, cell cycle control, apoptosis, as well as transcriptional control. In this work, we have found that BRCA1 is involved in regulating TGF-β1/Smad pathway. The loss of endogenous BRCA1 greatly attenuated TGF-β1-induced growth inhibition and cell cycle G1 arrest. BRCA1 greatly maintains stability of Smad4 protein, and the loss of BRCA1 results in Smad4 down-regulation, which is likely related to its downstream gene Gadd45a. Gadd45a is able to interact with β-Trcp1, a-F-box protein of SCF E3 ligase, and consequently suppresses the ubiquitin-degradation of Smad4 by SCF(β-trcp1), as reflected by the observations that the induction of Gadd45a substantially stabilizes Smad4 protein. In addition, exogenous expression of Gadd45a can largely rescue the protein level of Smad4 in BRCA1 deficient cells. These results further demonstrate that BRCA1 may act as an important negative regulator in cell cycle progression and tumorigenesis through regulating the stability of Smad4, and define a novel link that connects BRCA1 to TGF-β1/Smad pathway.
Copyright © 2015 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  BRCA1; Cell growth; Gadd45a; TGF-β1; Tumor suppressor gene; Tumorigenesis; Ubiquitin

Mesh:

Substances:

Year:  2015        PMID: 26022109      PMCID: PMC5528796          DOI: 10.1016/j.molonc.2015.05.002

Source DB:  PubMed          Journal:  Mol Oncol        ISSN: 1574-7891            Impact factor:   6.603


  45 in total

1.  A mechanism of repression of TGFbeta/ Smad signaling by oncogenic Ras.

Authors:  M Kretzschmar; J Doody; I Timokhina; J Massagué
Journal:  Genes Dev       Date:  1999-04-01       Impact factor: 11.361

2.  Gadd45a expression induces Bim dissociation from the cytoskeleton and translocation to mitochondria.

Authors:  Tong Tong; Junfang Ji; Shunqian Jin; Xianxing Li; Wenhong Fan; Yongmei Song; Minrong Wang; Zhihua Liu; Min Wu; Qimin Zhan
Journal:  Mol Cell Biol       Date:  2005-06       Impact factor: 4.272

3.  Dynamic changes of BRCA1 subnuclear location and phosphorylation state are initiated by DNA damage.

Authors:  R Scully; J Chen; R L Ochs; K Keegan; M Hoekstra; J Feunteun; D M Livingston
Journal:  Cell       Date:  1997-08-08       Impact factor: 41.582

4.  Role of Smad proteins and transcription factor Sp1 in p21(Waf1/Cip1) regulation by transforming growth factor-beta.

Authors:  K Pardali; A Kurisaki; A Morén; P ten Dijke; D Kardassis; A Moustakas
Journal:  J Biol Chem       Date:  2000-09-22       Impact factor: 5.157

5.  Transforming growth factor-beta-induced growth inhibition in a Smad4 mutant colon adenoma cell line.

Authors:  S P Fink; S E Swinler; J D Lutterbaugh; J Massagué; S Thiagalingam; K W Kinzler; B Vogelstein; J K Willson; S Markowitz
Journal:  Cancer Res       Date:  2001-01-01       Impact factor: 12.701

6.  Association of BRCA1 with Rad51 in mitotic and meiotic cells.

Authors:  R Scully; J Chen; A Plug; Y Xiao; D Weaver; J Feunteun; T Ashley; D M Livingston
Journal:  Cell       Date:  1997-01-24       Impact factor: 41.582

Review 7.  Mutations of TGFbeta signaling molecules in human disease.

Authors:  Kelly A Harradine; Rosemary J Akhurst
Journal:  Ann Med       Date:  2006       Impact factor: 4.709

8.  CHIP mediates degradation of Smad proteins and potentially regulates Smad-induced transcription.

Authors:  Linyu Li; Hong Xin; Xialian Xu; Mei Huang; Xinjun Zhang; Yue Chen; Shuping Zhang; Xin-Yuan Fu; Zhijie Chang
Journal:  Mol Cell Biol       Date:  2004-01       Impact factor: 4.272

9.  Restoration of SMAD4 by gene therapy reverses the invasive phenotype in pancreatic adenocarcinoma cells.

Authors:  Dan G Duda; Makoto Sunamura; Liviu P Lefter; Toru Furukawa; Tadaaki Yokoyama; Toshimasa Yatsuoka; Tadayoshi Abe; Hiroko Inoue; Fuyuhiko Motoi; Shin-ichi Egawa; Seiki Matsuno; Akira Horii
Journal:  Oncogene       Date:  2003-10-09       Impact factor: 9.867

10.  SMAD2, SMAD3 and SMAD4 mutations in colorectal cancer.

Authors:  Nicholas I Fleming; Robert N Jorissen; Dmitri Mouradov; Michael Christie; Anuratha Sakthianandeswaren; Michelle Palmieri; Fiona Day; Shan Li; Cary Tsui; Lara Lipton; Jayesh Desai; Ian T Jones; Stephen McLaughlin; Robyn L Ward; Nicholas J Hawkins; Andrew R Ruszkiewicz; James Moore; Hong-Jian Zhu; John M Mariadason; Antony W Burgess; Dana Busam; Qi Zhao; Robert L Strausberg; Peter Gibbs; Oliver M Sieber
Journal:  Cancer Res       Date:  2012-11-08       Impact factor: 12.701

View more
  5 in total

1.  BRCA1 regulates transforming growth factor-β (TGF-β1) signaling through Gadd45a by enhancing the protein stability of Smad4.

Authors:  Dan Li; Nan Kang; Junfang Ji; Qimin Zhan
Journal:  Mol Oncol       Date:  2015-05-14       Impact factor: 6.603

2.  Derivate isocorydine inhibits cell proliferation in hepatocellular carcinoma cell lines by inducing G2/M cell cycle arrest and apoptosis.

Authors:  Lijuan Chen; Hua Tian; Meng Li; Chao Ge; Fangyu Zhao; Lixing Zhang; Hong Li; Junxi Liu; Tingpu Wang; Ming Yao; Jinjun Li
Journal:  Tumour Biol       Date:  2015-11-23

Review 3.  TGFβ signaling networks in ovarian cancer progression and plasticity.

Authors:  Asha Kumari; Zainab Shonibare; Mehri Monavarian; Rebecca C Arend; Nam Y Lee; Gareth J Inman; Karthikeyan Mythreye
Journal:  Clin Exp Metastasis       Date:  2021-02-15       Impact factor: 5.150

4.  Plasma Protein Biomarkers Associated with Higher Ovarian Cancer Risk in BRCA1/2 Carriers.

Authors:  Hee-Sung Ahn; Jung Yoon Ho; Jiyoung Yu; Jeonghun Yeom; Sanha Lee; Soo Young Hur; Yuyeon Jung; Kyunggon Kim; Youn Jin Choi
Journal:  Cancers (Basel)       Date:  2021-05-11       Impact factor: 6.639

5.  TGF-β signaling proteins and CYP24A1 may serve as surrogate markers for progesterone calcitriol treatment in ovarian and endometrial cancers of different histological types.

Authors:  Ana Paucarmayta; Hannah Taitz; Yovanni Casablanca; Gustavo C Rodriguez; G Larry Maxwell; Kathleen M Darcy; Viqar Syed
Journal:  Transl Cancer Res       Date:  2019-08       Impact factor: 1.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.